NAFLD in Asia--as common and important as in the West (Q38086356)

28 August 2017

NAFLD in Asia--as common and important as in the West (English)

1 reference

28 August 2017

3

1 reference

28 August 2017

2

Vincent Wai-Sun Wong

0 references

Geoffrey Farrell

series ordinal

1

object named as

Geoffrey C Farrell

1 reference

PubMed ID

23458891

28 August 2017

language of work or name

English

0 references

publication date

5 March 2013

1 reference

Nature Reviews Gastroenterology & Hepatology

28 August 2017

1 reference

28 August 2017

10

1 reference

28 August 2017

307-318

1 reference

28 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2013.34

28 August 2017

0 references

cites work

Interactions of obesity and glucose-stimulated insulin secretion in familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver in Asia: Firmly entrenched and rapidly gaining ground

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease in Asia: a story of growth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

How should we manage patients with non-alcoholic fatty liver disease in 2007?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A position statement on NAFLD/NASH based on the EASL 2009 special conference

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Diagnosing steatohepatitis and predicting liver-related mortality in patients with NAFLD: two distinct concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Protective effect of alcohol consumption for fatty liver but not metabolic syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Hepatitis B virus infection and fatty liver in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The utility of radiological imaging in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Histopathology of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Histological features of non-alcoholic fatty liver disease: what is important?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Long-term follow-up of patients with NAFLD and elevated liver enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Relationship between uric acid and hepatic steatosis among Koreans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Epidemiology of non-alcoholic fatty liver disease in China.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Risk factors for liver steatosis in obese children and adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Association of raised liver transaminases with physical inactivity, increased waist-hip ratio, and other metabolic morbidities in severely obese children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Fatty liver and the metabolic syndrome among Shanghai adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Non-alcoholic fatty liver disease in Malaysia: A demographic, anthropometric, metabolic and histological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Epidemic obesity and type 2 diabetes in Asia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Ethnicity and nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Insulin resistance at diagnosis in Japanese children with type 2 diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Postprandial insulin secretion pattern is associated with histological severity in non-alcoholic fatty liver disease patients without prior known diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Parental history of type 2 diabetes mellitus, metabolic syndrome, and cardiometabolic risk factors in Asian Indian adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Predictors of fibrosis in Asian patients with non-alcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Diabetes and hepatocellular cancer risk: not only a matter of hyperglycemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Dietary habits and nutrient intake in non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the United States population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Liver cholesterol: is it playing possum in NASH?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Severe obesity is associated with novel single nucleotide polymorphisms of the ESR1 and PPARgamma locus in Han Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

APOC3 and PNPLA3 in non-alcoholic fatty liver disease: Need to clear the air

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The I148M PNPLA3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Genetic determinants of alcoholic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Variant in PNPLA3 is associated with alcoholic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Molecular dynamics simulation of PNPLA3 I148M polymorphism reveals reduced substrate access to the catalytic cavity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Hepatocellular carcinoma in nonalcoholic fatty liver cirrhosis and alcoholic cirrhosis: risk factor analysis in liver transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Hepatocellular carcinoma in non-alcoholic steatohepatitis: Growing evidence of an epidemic?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Clues from the carotids: an appraisal of cardiovascular disease risk in non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Significant correlations between severe fatty liver and risk factors for metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease is associated with coronary artery calcification.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

A survey of patterns of practice and perception of NAFLD in a large sample of practicing gastroenterologists in France

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Potential for statins in the chemoprevention and management of hepatocellular carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Statin use and reduced cancer-related mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

TNF-alpha as therapeutic target in NASH: tried, but not yet proven

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2013.34

Prevalence of non-alcoholic fatty liver in a hypercholesterolemic population of northwestern peninsular Malaysia

31 March 2020

1 reference

12 December 2020

Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study

1 reference

12 December 2020

NASH and cryptogenic cirrhosis: a histological analysis.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

Beneficial effects of pentoxifylline on hepatic steatosis, fibrosis and necroinflammation in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

[CLINICAL ASPECTS OF FATTY LIVER.]

1 reference

12 December 2020

Does non-alcoholic fatty liver disease predispose patients to type 2 diabetes in the absence of obesity?

1 reference

12 December 2020

Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Colorectal neoplasms in relation to non-alcoholic fatty liver disease in Korean women: a retrospective cohort study

1 reference

12 December 2020

Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps

1 reference

12 December 2020

Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?

1 reference

12 December 2020

Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2013.34

1 reference

28 August 2017

1 reference

PubMed ID

23458891